pq tirzepatide Compounded (GLP-1/GIP) How Does Tirzepatide Work? |

JAMA 330 , 16311640 (2023)

Special monitoring may be needed for diabetes medications (though AOD-9604 doesnt affect glucose metabolism), cardiovascular drugs, thyroid medications, or other growth hormone-related therapies

Taken together, GCGR agonism offers a promising yet complex strategy in cardiometabolic disease, as it promotes weight loss and energy expenditure while also increasing blood glucose, underscoring the need for dual- and triple-agonist approaches (GLP1R/GIPR/GCGR) that balance metabolic and CV effects

This is often where patients begin to notice a more consistent fullness after smaller meals

A more complete investigation of relevant human GSTs is required for understanding the scope of JS-K biotransformation and the consequent cellular effects in neoplastic as well as normal tissues

Patients who have struggled with rapid weight loss regain may benefit from slower titration and behavioral support, potentially extending the 20-pound timeline to 57 months but improving durability